Background and Aims: Interstitial lung disease is progressive, but there are few studies on the changes in quality of life and affecting symptoms over time. Therefore, we examined the time course of the chronic obstructive pulmonary disease assessment test (CAT) score to clarify the symptoms using the eight items in the CAT.
Methods: Sixty-three patients with interstitial lung disease were evaluated by the CAT repeatedly with an interval of 20 months on average, excluding the period of acute exacerbation. The hospital records for the pulmonary function test were also collected for analysis.
Results: The CAT score improved or stayed the same in 31 patients and deteriorated in the others. The duration from disease onset to the first evaluation in the improved group was shorter than that in the deteriorated group, and logistic analysis demonstrated that five years from onset was the cut-off point for deterioration (AUC = 0.75, P = 0.01). Symptoms in the improved group were all ameliorated except for chest tightness and confidence in leaving home. In the deteriorated group, chest tightness, breathlessness, activity limitation at home, less confidence in leaving home, and less energy were more frequently observed. The most common item in the CAT was breathlessness in all patients. Forced vital capacity and diffusion capacity of the lung for carbon monoxide at the first evaluation were more impaired in patients of the deteriorated group (P = 0.04 and = 0.008, respectively). Moreover, pulmonary function declined on repeated evaluations in patients of both groups.
Conclusion: Breathlessness may be the main symptom in interstitial lung disease, but quality of life can be improved in patients with a short duration from disease onset regardless of progressive impairment in pulmonary function. Improvement in quality of life becomes difficult over time due to poorer pulmonary function. To compare clinical characteristics and clinical outcomes of patients with IPAF to patients with connective tissue disease related-interstitial lung disease (CTD-ILD) and patients with idiopathic pulmonary fibro-
sis (IPF).
Methods: ILD patients who were consecutively enrolled in a single institution ILD cohort between 2008 and 2015 were evaluated for the study. Clinical data had been prospectively collected, while radiologic imaging and pathologic findings were re-reviewed for present study.
Results: Out of 409 patients with ILD, 56 (13.7%) patients met the classification of IPAF and 148 (36.2%) patients had idiopathic pulmonary fibrosis (IPF). Forty-four (10.8%) patients were diagnosed of CTD-ILD. The proportion of males (25.0%) in the IPAF group was low when compared to the CTD-ILD (38.6%) and IPF (63.1%) groups. Mean age and the proportion of ever smokers were significantly different between the three groups (P < 0.001 and P < 0.001, respectively). The IPAF group had the lowest proportion of patients with emphysema on high resolution CT (HRCT) (P = 0.004). There were no significant differences in pulmonary function test parameters between 3 groups (Table 1) . Among 56 IPAF patients, 36 (64.3%) patients showed nonspecific interstitial pneumonia (NSIP) pattern on HRCT. Among 12 IPAF patients who underwent surgical biopsy, organizing pneumonia was the most frequent histopathologic pattern (50%). Overall survival (OS) of IPAF was significantly better than the IPF groups (P = 0.005) ( Figure 1A) . After stratification by presence of emphysema, no significant difference in OS exists between the IPAF patients without emphysema and with emphysema (P = 0.713) ( Figure 1B 
